185 related articles for article (PubMed ID: 21690288)
1. In vitro evaluation of the type of interaction obtained by the combination of terbinafine and itraconazole, voriconazole, or amphotericin B against dematiaceous molds.
Biancalana FS; Lyra L; Schreiber AZ
Antimicrob Agents Chemother; 2011 Sep; 55(9):4485-7. PubMed ID: 21690288
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Ryder NS; Leitner I
Med Mycol; 2001 Feb; 39(1):91-5. PubMed ID: 11270414
[TBL] [Abstract][Full Text] [Related]
3. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Ortoneda M; Capilla J; Javier Pastor F; Pujol I; Guarro J
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):69-71. PubMed ID: 14761725
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota.
Gómez-López A; Cuenca-Estrella M; Mellado E; Rodríguez-Tudela JL
Diagn Microbiol Infect Dis; 2003 Mar; 45(3):199-202. PubMed ID: 12663161
[TBL] [Abstract][Full Text] [Related]
5. In vitro interactions between antifungals and methotrexate against Aspergillus spp.
Yang J; Wan Z; Wang X; Liu W; Li R
Mycopathologia; 2009 Nov; 168(5):237-42. PubMed ID: 19548112
[TBL] [Abstract][Full Text] [Related]
6. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
Espinel-Ingroff A
J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility testing of terbinafine alone and in combination with amphotericin B, itraconazole, or voriconazole against conidia and hyphae of dematiaceous molds.
Biancalana FS; Lyra L; Moretti ML; Schreiber AZ
Diagn Microbiol Infect Dis; 2011 Dec; 71(4):378-85. PubMed ID: 21945391
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.
Argenta JS; Santurio JM; Alves SH; Pereira DI; Cavalheiro AS; Spanamberg A; Ferreiro L
Antimicrob Agents Chemother; 2008 Feb; 52(2):767-9. PubMed ID: 18056274
[TBL] [Abstract][Full Text] [Related]
9. Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Buitrago MJ; Monzón A; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2003 Jul; 47(7):2339-41. PubMed ID: 12821493
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus.
Cuenca-Estrella M; Rodríguez-Tudela JL; Mellado E; Martínez-Suárez JV; Monzón A
J Antimicrob Chemother; 1998 Oct; 42(4):531-3. PubMed ID: 9818755
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B.
Oakley KL; Moore CB; Denning DW
J Antimicrob Chemother; 1998 Jul; 42(1):91-4. PubMed ID: 9700534
[TBL] [Abstract][Full Text] [Related]
12. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
Yu J; Li R; Zhang M; Liu L; Wan Z
Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Mosquera J; Sharp A; Moore CB; Warn PA; Denning DW
J Antimicrob Chemother; 2002 Aug; 50(2):189-94. PubMed ID: 12161398
[TBL] [Abstract][Full Text] [Related]
14. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis.
Cuenca-Estrella M; Gomez-Lopez A; Buitrago MJ; Mellado E; Garcia-Effron G; Rodriguez-Tudela JL
Antimicrob Agents Chemother; 2006 Jun; 50(6):2248-50. PubMed ID: 16723597
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
16. In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Barchiesi F; Di Francesco LF; Compagnucci P; Arzeni D; Giacometti A; Scalise G
J Antimicrob Chemother; 1998 Jan; 41(1):59-65. PubMed ID: 9511038
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity (MIC and MFC) of voriconazole, amphotericin B, and itraconazole against 192 filamentous fungi: the GISIA-2 study.
Morace G; Drago M; Scaltrito MM; Conti S; Fanti F; Polonelli L;
J Chemother; 2007 Oct; 19(5):508-13. PubMed ID: 18073149
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi.
Johnson EM; Szekely A; Warnock DW
J Antimicrob Chemother; 1998 Dec; 42(6):741-5. PubMed ID: 10052897
[TBL] [Abstract][Full Text] [Related]
19. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates.
Meletiadis J; Mouton JW; Meis JF; Verweij PE
Antimicrob Agents Chemother; 2003 Jan; 47(1):106-17. PubMed ID: 12499177
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
